Last update: Dec. 1, 2004

Dexfenfluramine

High Risk for breastfeeding


Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T½.
Read the Comment.

Anti-depressive drug that has been used as an anorexigenic. It is a very risky drug. No adverse effect has been described. Breastfeeding women recover their pre-pregnancy body weight sooner than bottle-feeding mothers. Withdrawn from the market in Spain.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Dexfenfluramine belongs to this group or family:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 68 %
Molecular weight 231 daltons
Protein Binding 36 %
Tmax 2 hours
T1/2 20 hours

References

  1. AEMPS Retirada del mercado de los medicamentos anorexígenos de acción central. 2000 Full text (in our servers)

Total visits

1,776

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM